These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25999161)

  • 21. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
    Lee S; Koo HN; Lee BH
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):617-22. PubMed ID: 16357945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free energy calculation provides insight into the action mechanism of selective PARP-1 inhibitor.
    Cao R
    J Mol Model; 2016 Apr; 22(4):74. PubMed ID: 26969680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel class of substituted spiro [quinazoline-2,1'-cyclohexane] derivatives as effective PPAR-1 inhibitors: molecular modeling, synthesis, cytotoxic and enzyme assay evaluation.
    Amin KM; Anwar MM; Syam YM; Khedr MA; Kamel MM; Kassem EM
    Acta Pol Pharm; 2013; 70(4):687-708. PubMed ID: 23923393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
    Costantino G; Macchiarulo A; Camaioni E; Pellicciari R
    J Med Chem; 2001 Nov; 44(23):3786-94. PubMed ID: 11689065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitors.
    Tao M; Park CH; Bihovsky R; Wells GJ; Husten J; Ator MA; Hudkins RL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):938-42. PubMed ID: 16290935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach.
    Baptista SJ; Silva MM; Moroni E; Meli M; Colombo G; Dinis TC; Salvador JA
    PLoS One; 2017; 12(1):e0170846. PubMed ID: 28122037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase.
    Loh VM; Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Eversley PJ; Gomez S; Hoare J; Kerrigan F; Matthews IT; Menear KA; Martin NM; Newton RF; Paul J; Smith GC; Vile J; Whittle AJ
    Bioorg Med Chem Lett; 2005 May; 15(9):2235-8. PubMed ID: 15837300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing PARP1-inhibitor complexes for the development of novel inhibitors.
    Saqib U; Baig MS
    Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):43-52. PubMed ID: 25346248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
    Le TV; Suh JH; Kim N; Park HJ
    Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of Poly (ADP-ribose) polymerase (PARP) homologues in human ejaculated sperm and its correlation with sperm maturation.
    Jha R; Agarwal A; Mahfouz R; Paasch U; Grunewald S; Sabanegh E; Yadav SP; Sharma R
    Fertil Steril; 2009 Mar; 91(3):782-90. PubMed ID: 18339380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
    Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies Employed for the Development of PARP Inhibitors.
    Canan S; Maegley K; Curtin NJ
    Methods Mol Biol; 2017; 1608():271-297. PubMed ID: 28695516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PARP inhibitors for cancer therapy.
    Curtin NJ
    Expert Rev Mol Med; 2005 Mar; 7(4):1-20. PubMed ID: 15836799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine.
    Nilov D; Maluchenko N; Kurgina T; Pushkarev S; Lys A; Kutuzov M; Gerasimova N; Feofanov A; Švedas V; Lavrik O; Studitsky VM
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase.
    Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Kerrigan F; Loh VM; Martin NM; Menear KA; Smith GC
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1040-4. PubMed ID: 16290932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of low micromolar dual inhibitors for aldose reductase (ALR2) and poly (ADP-ribose) polymerase (PARP-1) using structure based design approach.
    Chadha N; Silakari O
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2324-2330. PubMed ID: 28438542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.